Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed,
and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government
operating status and resumption of normal operations can be found at opm.gov.
Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 70 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Type 2 diabetes patients on stable metformin
18-70 years old
Willing to perform at least 4 capillary blood glucose tests per day
Type 2 diabetes patients on any other antidiabetic treatment
Patients listed in other trials
Patients with significant diabetic organ disease or complications.
Other protocol-defined inclusion/exclusion criteria may apply